Stress Test Pathways Against Venture DNA Parameters
The founder evaluates each strategic option against core venture DNA parameters, including investor return expectations, founder mission alignment, capital efficiency, and IP defensibility. The options are put through scenario analysis to test resilience against market headwinds and operational constraints.
This testing filters out strategic options that contradict core investor mandates, founder motivations, or operational capabilities. It prevents the venture from committing resources to strategic paths that are fundamentally unviable or misaligned.
The founder provides a rubric-based evaluation documenting how each option scores against risk tolerance, return hurdles, and governance restrictions. The output must highlight clear alignment or conflict points with existing venture agreements.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
What evidence demonstrates that your preferred option satisfies the specific return hurdles of your lead investors?
- 2
Why did you assume your core IP rights and regulatory approvals are transferable under the proposed licensing or M&A paths?
- 3
How does this strategic trajectory hold up if market adoption slows by fifty per cent over the next two quarters?
- 4
Which elements of your venture DNA are non-negotiable, and how severely does each path compromise them?
- 5
How have you stress-tested team retention and key-person risk under a scale versus wind-down scenario?